These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10577807)

  • 1. Local and systemic immunotherapy in nasal allergy.
    Palma-Carlos AG; Palma-Carlos ML; Spínola Santos A; Santos C; Pedro E; Pregal A
    Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S207-11. PubMed ID: 10577807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy and mast cell activation.
    Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A
    Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
    Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific nasal provocation test with powder allergen.
    Salzano FA
    Allergy; 1997; 52(33 Suppl):32-5. PubMed ID: 9188946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions.
    Klimek L; Wolf H; Mewes T; Dormann D; Reske-Kunz A; Schnitker J; Mann W
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):47-53. PubMed ID: 9893184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH; Devalia JL; Duddle JM; Hamilton SA; Davies RJ
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tryptase determination in nasal washings in patients with allergic rhinitis].
    Khreisat I; Simonetta A; Attinà EL; Monasterolo G; Bertone GF; Beccaria T; Rossi RE
    Acta Otorhinolaryngol Ital; 1997 Feb; 17(1):22-5. PubMed ID: 9412151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators in naturally occurring rhinitis.
    Wilson SJ; Lau L; Howarth PH
    Clin Exp Allergy; 1998 Feb; 28(2):220-7. PubMed ID: 9515596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.
    van Hage-Hamsten M; Johansson E; Roquet A; Peterson C; Andersson M; Greiff L; Vrtala S; Valenta R; Grönneberg R
    Clin Exp Allergy; 2002 Oct; 32(10):1448-53. PubMed ID: 12372124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term efficacy of nasal immunotherapy.
    Palma-Carlos AG; Santos AS; Pregal A
    Allerg Immunol (Paris); 1998 Jan; 30(1):14-7. PubMed ID: 9503098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
    Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
    Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal immunotherapy in weed-induced allergic rhinitis.
    Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G; Drago A; Esposito Pellitteri M; Candore G; Colombo A; Gervasi F; Pacor ML; Purello D'Ambrosio F; Caruso C
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation.
    KleinJan A; McEuen AR; Dijkstra MD; Buckley MG; Walls AF; Fokkens WJ
    J Allergy Clin Immunol; 2000 Oct; 106(4):677-86. PubMed ID: 11031338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal application of immunotherapy.
    Ascione E; De Lucia A; Imperiali M; Varricchio A; Motta G
    Chem Immunol Allergy; 2003; 82():89-98. PubMed ID: 12947995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptase in nasal fluid is a useful marker of allergic rhinitis.
    Rasp G; Hochstrasser K
    Allergy; 1993 Feb; 48(2):72-4. PubMed ID: 8457035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of local hyperthermia on allergen-induced nasal congestion and mediator release.
    Johnston SL; Price JN; Lau LC; Walls AF; Walters C; Feather IH; Holgate ST; Howarth PH
    J Allergy Clin Immunol; 1993 Dec; 92(6):850-6. PubMed ID: 8258620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal non-allergic rhinitis (SNAR)--a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis.
    Wedbäck A; Enbom H; Eriksson NE; Movérare R; Malcus I
    Rhinology; 2005 Jun; 43(2):86-92. PubMed ID: 16008061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loratadine reduces allergen-induced mucosal output of alpha 2-macroglobulin and tryptase in allergic rhinitis.
    Greiff L; Persson CG; Svensson C; Enander I; Andersson M
    J Allergy Clin Immunol; 1995 Jul; 96(1):97-103. PubMed ID: 7542675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal allergen challenge and immunotherapy control.
    Palma-Carlos AG; Palma-Carlos ML; Branco-Ferreira M; Spinola A; Santos MC; Lopes-Pregral A
    Allerg Immunol (Paris); 1998 May; 30(5):153-6. PubMed ID: 9657024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.